Delivery Order SPE2DE21D0005-SPE2D625F0XV1

Award Date 6/5/25
Potential Completion Date 6/10/25
Potential Value $3K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company specializing in advanced wound care, surgical biologics, and tissue regeneration products. The contract, valued at $3,420.00, is for the supply of PURAPLY MZ 500MG, a wound care product. The contract is a fixed-price with economic price adjustment, with a completion date of March 20, 2025. The contract does not have a set-aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The contract, valued at $4,645.00, is for the supply of PURAPLY MZ 500MG, a regenerative wound care product. Organogenesis is a for-profit organization and a manufacturer of goods. The contract does not utilize any set-aside designations. This delivery order is part of a larger $49.5 million multiple-award Indefinite Delivery...
This $8,500 fixed-price delivery order was awarded to Organogenesis Inc., a regenerative medicine company, by the Defense Logistics Agency (DLA) Troop Support Medical on September 11, 2024. The order is for the supply of PURAPLY AM XT, a wound care product, with an ultimate completion date of September 16, 2024. Organogenesis is a key supplier of advanced wound care and surgical biologics products to the U.S. government, primarily serving the Department of Defense and Department of Veterans...
This contract award to Organogenesis Inc. is for the delivery of PURAPLY MZ 500MG medical supplies. The contract, valued at $9,375.00, is a fixed-price delivery order with economic price adjustment, issued by the Defense Logistics Agency (DLA) Troop Support Medical. Organogenesis Inc. is a regenerative medicine company that specializes in advanced wound care and surgical biologics. The company has held several significant Indefinite Delivery Vehicles (IDVs) with federal agencies, including a $25...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,118.88 fixed-price delivery order with economic price adjustment to Organogenesis Inc., a leading regenerative medicine company based in Canton, Massachusetts. The order is for PURAPLY AM (2x2) 4 SQ CM, an advanced wound care product. This order is part of Organogenesis' broader federal contract vehicles, including a $49.5 million multiple-award Indefinite Delivery Contract with DLA Troop Support Medical for wound care...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts. The contract is a $1,140 fixed-price delivery order for PURAPLY MZ 500MG, a wound care product. The contract is not associated with a set-aside program and has an ultimate completion date of April 8, 2025. Organogenesis Inc. is a for-profit manufacturer that specializes in advanced wound care, surgical...
This is a $1,678.32 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The contract is for the supply of PURAPLY AM (2x2) 4 sq cm wound care dressings, with a period of performance through June 4, 2024. Organogenesis holds several significant Indefinite Delivery Vehicles (IDVs) with federal agencies, including a $49.5 million multiple-award IDC with the DLA for...
This is a $1,118.88 fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading manufacturer of regenerative medicine products. The order is for PURAPLY AM wound care dressings, which are advanced skin substitutes used to support tissue repair and regeneration. Organogenesis is an experienced federal contractor, holding several significant Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and DLA...
This is a $1,118.88 fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company, to provide PURAPLY AM wound dressings. The order is part of a larger $49.5 million multiple-award indefinite delivery contract (IDC) that Organogenesis holds with DLA for wound care dressings, discs, and other medical materials through May 2026. Organogenesis also maintains Blanket Purchase Agreements valued up to $7 million...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company specializing in advanced wound care and surgical biologics products. The contract, valued at $8,150.00, is for the delivery of PURAPLY MZ 500MG, a wound care product. Organogenesis holds several significant Indefinite Delivery Vehicles (IDVs) with federal agencies, including a $25 million single-award Indefinite Delivery Contract...
  • SPE2DE21D0005
    Indefinite Delivery Contract
  • SPE2DE21D0005-SPE2D625F0XV1
    Delivery Order

This is a delivery order contract awarded to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of PURAPLY MICRONIZED, 500MG, a wound care product, with a ceiling value of $3,008. The contract has a fixed price with economic price adjustment pricing type and a completion date of June 10, 2025. Organogenesis is a key supplier of medical products, including skin substitutes, wound matrices, and tissue repair technologies, to federal healthcare agencies such as the Department of Veterans Affairs (VA) and the DLA. The company maintains several significant federal Indefinite Delivery Vehicles (IDVs) with the VA and DLA, worth tens of millions of dollars, which enable it to provide a comprehensive range of regenerative medicine products to support medical treatments across military and veteran healthcare programs. This specific award is not associated with a set-aside designation, indicating Organogenesis competed as a standard commercial vendor.

Generated 9/4/25, 9:48 AM